Virtual Reality Training for Heart Rate Variability and Recovery Heart Rate

May 21, 2025 updated by: Riphah International University

Effects of Virtual Reality Training on Heart Rate Variability and Recovery Heart Rate in Sedentary Individuals

To determine effects of VR training on Heart Rate Variability (HRV), Recovery Heart rate (RHR), Rate Pressure Product (RPP) and Rate of Perceived Exertion (RPE) in sedentary Individuals. Sedentary behavior is a significant public health concern associated with various chronic diseases and reduced quality of life. By elucidating the potential of virtual reality training as an innovative approach to promote physical activity and improve cardiovascular health, this research contributes to addressing the growing burden of sedentary lifestyle-related health conditions.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Virtual reality (VR) training in cardiopulmonary rehabilitation (CR) offers an innovative approach to traditional exercise programs by incorporating enjoyable activities. Utilizing VR enhances cardiopulmonary endurance training and promotes the beneficial effects of CR by engaging patients in fun and challenging activities. This approach aims to increase motivation and adherence to CR over an extended period, resulting in improved mental and physical outcomes compared to conventional CR programs

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Rawalpindi, Punjab, Pakistan, 26054
        • Pakistan Railway General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Sedentary Individuals (IPAQ-short version) < 3.3 METS daily
  • Daily sitting time≤7 hours

Exclusion Criteria:

  • Decline Consent
  • Known cases of systemic or Cardiovascular Diseases.
  • Obese (Asian BMI) > 29.9
  • Any contra-indication to exercise/ Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Virtual Reality Training
Virtual reality training (X-BOX) for 6 weeks
Other: Virtual Reality Training

Virtual reality training (X-BOX). Table tennis

  • Frequency: 3 day per week
  • Intensity: Mild to moderate as per Game. Exer-game ( River Rush)
  • Time: total 30 minute of training with 5 min warm and 5 min cool down.
  • Type: aerobic exercise
Active Comparator: Cycle Ergometer
Aerobic activity on cycle ergometer for 6 weeks
Other: Cycle Ergometer
  • Frequency: 3 days per week.
  • Intensity: 40-60% of HRR
  • Time: total 30 minutes with 5 min warm up and 5 min cool down
  • Type: aerobic exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate Variability (HRV)
Time Frame: 2 weeks, 4 weeks, 6 weeks
From baseline till 2nd, 4th, and 6th weeks measured through wireless ECG device which measures inter-beat (RR) intervals while doing physical activities. In adults , average HRV is 42 milliseconds.
2 weeks, 4 weeks, 6 weeks
Recovery Heart Rate
Time Frame: 2 weeks, 4 weeks, 6 weeks
From baseline till 2nd, 4th, and 6th weeks measured through pulse oximeter. One-minute HRR for the average person is between 15 to 25 bpm, with a higher number indicating a quicker recovery and a potentially healthier heart.
2 weeks, 4 weeks, 6 weeks
Rate Pressure Product
Time Frame: 2 weeks, 4 weeks, 6 weeks
Changes from baseline to 2 weeks, 4 weeks and 6 weeks after the intervention, measured through product of heart rate and systolic blood pressure, is a very reliable indicator of myocardial oxygen demand. An RPP above 20,000 mmHg per minute is considered healthy, whereas anything below 16,000 mmHg is considered insufficient.
2 weeks, 4 weeks, 6 weeks
Rating of Perceived Exertion (RPE)
Time Frame: 2 weeks, 4 weeks, 6 weeks
Changes from baseline to 2 weeks, 4 weeks and 6 weeks after the intervention, measured through Borg RPE scale for measuring an individual's effort and exertion, breathlessness and fatigue during physical work. The RPE scale ranges from 6 to 20, each gradually related to the respondent's perceived exertion level.
2 weeks, 4 weeks, 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Riphah International University

Investigators

  • Principal Investigator: Mehwish Waseem, MSPT-CPPT, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2024

Primary Completion (Actual)

May 1, 2025

Study Completion (Actual)

May 15, 2025

Study Registration Dates

First Submitted

November 25, 2024

First Submitted That Met QC Criteria

November 25, 2024

First Posted (Actual)

November 27, 2024

Study Record Updates

Last Update Posted (Actual)

May 25, 2025

Last Update Submitted That Met QC Criteria

May 21, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Rec/01894 Javeria Shahzadi

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sedentary Behavior

Clinical Trials on Virtual Reality Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe